Interferon Alfa-2b or Not 2b? Significant Differences Exist in the Decision-Making Process between Melanoma Patients Who Accept or Decline High-Dose Adjuvant Interferon Alfa-2b Treatment

Journal Article

Full Text

Duke Authors

Cited Authors

  • BRAMLETTE, TB; LAWSON, DH; WASHINGTON, CV; VELEDAR, E; JOHNS, BR; BRISMAN, SF; ABRAMOVA, L; CHEN, SC

Published Date

  • January 1, 2007

Published In

Volume / Issue

  • 33 / 1

Start / End Page

  • 11 - 16

Published By

International Standard Serial Number (ISSN)

  • 1076-0512

Digital Object Identifier (DOI)

  • 10.1097/00042728-200701000-00002

Language

  • en